453 related articles for article (PubMed ID: 23806880)
1. Structure, function and regulation of the hsp90 machinery.
Li J; Buchner J
Biomed J; 2013; 36(3):106-17. PubMed ID: 23806880
[TBL] [Abstract][Full Text] [Related]
2. The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones.
Li J; Soroka J; Buchner J
Biochim Biophys Acta; 2012 Mar; 1823(3):624-35. PubMed ID: 21951723
[TBL] [Abstract][Full Text] [Related]
3. The Hsp90 molecular chaperone: an open and shut case for treatment.
Pearl LH; Prodromou C; Workman P
Biochem J; 2008 Mar; 410(3):439-53. PubMed ID: 18290764
[TBL] [Abstract][Full Text] [Related]
4. Hsp90: structure and function.
Jackson SE
Top Curr Chem; 2013; 328():155-240. PubMed ID: 22955504
[TBL] [Abstract][Full Text] [Related]
5. The chaperone Hsp90: changing partners for demanding clients.
Röhl A; Rohrberg J; Buchner J
Trends Biochem Sci; 2013 May; 38(5):253-62. PubMed ID: 23507089
[TBL] [Abstract][Full Text] [Related]
6. Impact of Posttranslational Modifications on the Anticancer Activity of Hsp90 Inhibitors.
Woodford MR; Dunn D; Miller JB; Jamal S; Neckers L; Mollapour M
Adv Cancer Res; 2016; 129():31-50. PubMed ID: 26916000
[TBL] [Abstract][Full Text] [Related]
7. Hsp90: breaking the symmetry.
Mayer MP; Le Breton L
Mol Cell; 2015 Apr; 58(1):8-20. PubMed ID: 25839432
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Asymmetry in Hsp90 Dimers.
Flynn JM; Mishra P; Bolon DN
J Mol Biol; 2015 Sep; 427(18):2904-11. PubMed ID: 25843003
[TBL] [Abstract][Full Text] [Related]
9. Structure and mechanism of the Hsp90 molecular chaperone machinery.
Pearl LH; Prodromou C
Annu Rev Biochem; 2006; 75():271-94. PubMed ID: 16756493
[TBL] [Abstract][Full Text] [Related]
10. Constantly updated knowledge of Hsp90.
Terasawa K; Minami M; Minami Y
J Biochem; 2005 Apr; 137(4):443-7. PubMed ID: 15858167
[TBL] [Abstract][Full Text] [Related]
11. The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins.
McLaughlin SH; Sobott F; Yao ZP; Zhang W; Nielsen PR; Grossmann JG; Laue ED; Robinson CV; Jackson SE
J Mol Biol; 2006 Feb; 356(3):746-58. PubMed ID: 16403413
[TBL] [Abstract][Full Text] [Related]
12. [Hsp90--a target for anticancer therapy].
Růcková E; Müller P; Vojtesek B
Klin Onkol; 2011; 24(5):329-37. PubMed ID: 22070013
[TBL] [Abstract][Full Text] [Related]
13. Functional specificity of co-chaperone interactions with Hsp90 client proteins.
Riggs DL; Cox MB; Cheung-Flynn J; Prapapanich V; Carrigan PE; Smith DF
Crit Rev Biochem Mol Biol; 2004; 39(5-6):279-95. PubMed ID: 15763706
[TBL] [Abstract][Full Text] [Related]
14. The Hsp90 chaperone machinery: from structure to drug development.
Hahn JS
BMB Rep; 2009 Oct; 42(10):623-30. PubMed ID: 19874705
[TBL] [Abstract][Full Text] [Related]
15. Hsp90: a chaperone for protein folding and gene regulation.
Zhao R; Houry WA
Biochem Cell Biol; 2005 Dec; 83(6):703-10. PubMed ID: 16333321
[TBL] [Abstract][Full Text] [Related]
16. The HSP90 complex of plants.
Kadota Y; Shirasu K
Biochim Biophys Acta; 2012 Mar; 1823(3):689-97. PubMed ID: 22001401
[TBL] [Abstract][Full Text] [Related]
17. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
[TBL] [Abstract][Full Text] [Related]
18. Hsp70 and Hsp90--a relay team for protein folding.
Wegele H; Müller L; Buchner J
Rev Physiol Biochem Pharmacol; 2004; 151():1-44. PubMed ID: 14740253
[TBL] [Abstract][Full Text] [Related]
19. Detecting Posttranslational Modifications of Hsp90.
Sager RA; Woodford MR; Neckers L; Mollapour M
Methods Mol Biol; 2018; 1709():209-219. PubMed ID: 29177662
[TBL] [Abstract][Full Text] [Related]
20. HSP90 and the chaperoning of cancer.
Whitesell L; Lindquist SL
Nat Rev Cancer; 2005 Oct; 5(10):761-72. PubMed ID: 16175177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
